Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06449209
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-06-03
Brief Title:
Safety Preliminary Effectiveness of BNT327 an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy
Sponsor:
BioNTech SE
Organization:
BioNTech SE
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Small-cell Lung Cancer |
| Extensive-stage Small-cell Lung Cancer |
Keywords:
| Name | View |
|---|---|
| Programmed Death Ligand-1 PDL-1 | View |
| Programmed Death-1 monoclonal antibodies | View |
| Combination chemotherapy | View |
| Anti vascular endothelial growth factor VEGF | View |
| Previously treated small-cell lung cancer | View |
| Untreated extensive-stage small-cell lung cancer | View |
| Dose optimization | View |
| Time to progression | View |
| Programmed Death-1 PD-1 | View |